Fluvastatin Capsule
Product Images NDC 63629-8812

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluvastatin (NDC 63629-8812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fluvastatin (Image 1)

Chemical structure of Fluvastatin, showing the molecular configuration including rings, hydroxyl groups, and a sodium ion.*

FDA Label Image

1 (Image 2)

A Kaplan-Meier survival curve graph showing the percentage of patients without events over 4.5 years since randomization, comparing Fluvastatin 80 mg to placebo. The graph includes statistical data such as Cox P-Value, Log-Rank P-Value, and Hazard Ratio with a 95% confidence interval. A table below shows the number of patients at risk and survival percentage at different time points.*

FDA Label Image

1 (Image 3)

A forest plot chart illustrating the incidence and risk reduction percentages for various cardiac events comparing fluvastatin versus placebo. It includes primary and secondary endpoints such as cardiac death, nonfatal myocardial infarction, revascularization, and noncardiac death, with Cox risk ratios and confidence intervals displayed graphically.*

FDA Label Image

1 (Image 4)

Bar chart showing the change in minimum lumen diameter (mm) comparing Fluvastatin 20 mg monotherapy, all patients group, and combination therapy with cholestyramine (CME) against placebo. The graph includes p-values indicating statistical significance for each comparison.*

FDA Label Image

1 (Image 5)

Bar chart depicting change in percent diameter stenosis comparing Fluvastatin versus placebo in three groups: Monotherapy, All Patients, and Combination Therapy with cholestyramine (CME). Values show lower stenosis changes for Fluvastatin compared to placebo across groups, with p-values indicating statistical significance for Monotherapy and All Patients, but not Combination Therapy.*

FDA Label Image

Label (Lbl636298812)

Fluvastatin Capsules, USP 20 mg oral capsules label showing the NDC 63629-8812-1. The label includes dosage strength 20 mg, the Bryant Ranch Prepack logo, and states Rx only with a package size of 100 capsules. Storage instructions and cautions about keeping medication out of reach of children are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.